
The US health watchdog has approved Alecensa, a drug for people with certain types of non-small cell lung cancer manufactured …

Roche has revealed promising trial data from two lung cancer treatments with one improving survival and the other shrinking tumours. …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?


